Furthermore, participants with high copeptin concentration have an increased risk for all components of the metabolic syndrome (6, 9, 10), as well as cardiovascular disease and premature mortality; this increased risk is seen both in patients with diabetes and in the general population (11–13). The gene discussed is AVP; the disease is diabetes mellitus.